• Je něco špatně v tomto záznamu ?

Continuum of sensory profiles in diabetes mellitus patients with and without neuropathy and pain

J. Raputova, A. Rajdova, J. Vollert, I. Srotova, C. Rebhorn, N. Üçeyler, F. Birklein, C. Sommer, E. Vlckova, J. Bednarik

. 2022 ; 26 (10) : 2198-2212. [pub] 20220915

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22032856

BACKGROUND: Quantitative sensory testing (QST) assesses the functional integrity of small and large nerve fibre afferents and central somatosensory pathways; QST was assumed to provide insight into the mechanisms of neuropathy. We analysed QST profiles and phenotypes in patients with diabetes mellitus to study whether these could differentiate patients with and without pain and neuropathy. METHODS: A standardized QST protocol was performed and 'loss and gain of function' abnormalities were analysed in four groups of subjects: diabetic patients with painful (pDSPN; n = 220) and non-painful distal symmetric polyneuropathy (nDSPN; n = 219), diabetic patients without neuropathy (DM; n = 23) and healthy non-diabetic subjects (n = 37). Based on the QST findings, diabetic subjects were further stratified into four predefined prototypic phenotypes: sensory loss (SL), thermal hyperalgesia (TH), mechanical hyperalgesia (MH) and healthy individuals. RESULTS: Patients in the pDSPN group showed the greatest hyposensitivity ('loss of function'), and DM patients showed the lowest, with statistically significant increases in thermal, thermal pain, mechanical and mechanical pain sensory thresholds. Accordingly, the frequency of the SL phenotype was significantly higher in the pDSPN subgroup (41.8%), than expected (p < 0.0042). The proportion of 'gain of function' abnormalities was low in both pDSPN and nDSPN patients without significant differences. CONCLUSIONS: There is a continuum in the sensory profiles of diabetic patients, with a more pronounced sensory loss in pDSPN group probably reflecting somatosensory nerve fibre degeneration. An analysis of 'gain of function' abnormalities (allodynia, hyperalgesia) did not offer a key to understanding the pathophysiology of spontaneous diabetic peripheral neuropathic pain. SIGNIFICANCE: This article, using quantitative sensory testing profiles in large cohorts of diabetic patients with and without polyneuropathy and pain, presents a continuum in the sensory profiles of diabetic patients, with more pronounced 'loss of function' abnormalities in painful polyneuropathy patients. Painful diabetic polyneuropathy probably represents a 'more progressed' type of neuropathy with more pronounced somatosensory nerve fibre degeneration. The proportion of 'gain of function' sensory abnormalities was low, and these offer limited understanding of pathophysiological mechanisms of spontaneous neuropathic pain.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032856
003      
CZ-PrNML
005      
20230131151137.0
007      
ta
008      
230120s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ejp.2034 $2 doi
035    __
$a (PubMed)36069121
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Raputova, Jana $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a Continuum of sensory profiles in diabetes mellitus patients with and without neuropathy and pain / $c J. Raputova, A. Rajdova, J. Vollert, I. Srotova, C. Rebhorn, N. Üçeyler, F. Birklein, C. Sommer, E. Vlckova, J. Bednarik
520    9_
$a BACKGROUND: Quantitative sensory testing (QST) assesses the functional integrity of small and large nerve fibre afferents and central somatosensory pathways; QST was assumed to provide insight into the mechanisms of neuropathy. We analysed QST profiles and phenotypes in patients with diabetes mellitus to study whether these could differentiate patients with and without pain and neuropathy. METHODS: A standardized QST protocol was performed and 'loss and gain of function' abnormalities were analysed in four groups of subjects: diabetic patients with painful (pDSPN; n = 220) and non-painful distal symmetric polyneuropathy (nDSPN; n = 219), diabetic patients without neuropathy (DM; n = 23) and healthy non-diabetic subjects (n = 37). Based on the QST findings, diabetic subjects were further stratified into four predefined prototypic phenotypes: sensory loss (SL), thermal hyperalgesia (TH), mechanical hyperalgesia (MH) and healthy individuals. RESULTS: Patients in the pDSPN group showed the greatest hyposensitivity ('loss of function'), and DM patients showed the lowest, with statistically significant increases in thermal, thermal pain, mechanical and mechanical pain sensory thresholds. Accordingly, the frequency of the SL phenotype was significantly higher in the pDSPN subgroup (41.8%), than expected (p &lt; 0.0042). The proportion of 'gain of function' abnormalities was low in both pDSPN and nDSPN patients without significant differences. CONCLUSIONS: There is a continuum in the sensory profiles of diabetic patients, with a more pronounced sensory loss in pDSPN group probably reflecting somatosensory nerve fibre degeneration. An analysis of 'gain of function' abnormalities (allodynia, hyperalgesia) did not offer a key to understanding the pathophysiology of spontaneous diabetic peripheral neuropathic pain. SIGNIFICANCE: This article, using quantitative sensory testing profiles in large cohorts of diabetic patients with and without polyneuropathy and pain, presents a continuum in the sensory profiles of diabetic patients, with more pronounced 'loss of function' abnormalities in painful polyneuropathy patients. Painful diabetic polyneuropathy probably represents a 'more progressed' type of neuropathy with more pronounced somatosensory nerve fibre degeneration. The proportion of 'gain of function' sensory abnormalities was low, and these offer limited understanding of pathophysiological mechanisms of spontaneous neuropathic pain.
650    12
$a diabetes mellitus $7 D003920
650    12
$a diabetické neuropatie $7 D003929
650    _2
$a lidé $7 D006801
650    _2
$a hyperalgezie $x etiologie $7 D006930
650    12
$a neuralgie $7 D009437
650    _2
$a měření bolesti $x metody $7 D010147
650    _2
$a práh bolesti $x fyziologie $7 D017288
650    12
$a polyneuropatie $7 D011115
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rajdova, Aneta $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Vollert, Jan $u Pain Research, Faculty of Medicine, Department of Surgery &amp; Cancer, Chelsea and Westminster Campus, Imperial College London, London, UK $u Medical Faculty Mannheim, Neurophysiology, Centre for Biomedicine and Medical Technology Mannheim (CBTM), Ruprecht-Karls-University, Heidelberg, Germany
700    1_
$a Srotova, Iva $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Rebhorn, Cora $u Department of Neurology, University Medical Centre, Mainz, Germany
700    1_
$a Üçeyler, Nurcan $u Department of Neurology, University of Würzburg, Germany
700    1_
$a Birklein, Frank $u Department of Neurology, University Medical Centre, Mainz, Germany
700    1_
$a Sommer, Claudia $u Department of Neurology, University of Würzburg, Germany
700    1_
$a Vlckova, Eva $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Bednarik, Josef $u Department of Neurology, Centre for Neuromuscular Diseases (Associated National Centre in the European Reference Network ERN EURO-NMD), University Hospital Brno, Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000174202383
773    0_
$w MED00158145 $t European journal of pain (London, England) $x 1532-2149 $g Roč. 26, č. 10 (2022), s. 2198-2212
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36069121 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151133 $b ABA008
999    __
$a ok $b bmc $g 1891540 $s 1184191
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 26 $c 10 $d 2198-2212 $e 20220915 $i 1532-2149 $m European journal of pain $n Eur J Pain $x MED00158145
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

    Možnosti archivace